Positive News SentimentPositive NewsNYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $9.08 +0.16 (+1.79%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$9.08 0.00 (-0.01%) As of 06/23/2026 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About InfuSystem Stock (NYSE:INFU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InfuSystem alerts:Sign Up Key Stats Today's Range$8.70▼$9.1650-Day Range$8.21▼$10.7952-Week Range$5.38▼$11.04Volume118,280 shsAverage Volume150,210 shsMarket Capitalization$183.25 millionP/E Ratio151.36Dividend YieldN/APrice Target$15.00Consensus RatingModerate Buy Company Overview InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards. In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions. By integrating connected infusion pumps with data analytics and telehealth platforms, the company enables healthcare providers to monitor therapy progress, optimize patient outcomes and improve staff efficiency. This end-to-end model supports a broad range of IV infusion therapies, including chemotherapy, pain management and antibiotic administration. Headquartered in St. Petersburg, Florida, InfuSystem was founded in the late 1980s and has grown to serve healthcare facilities across the United States and select international markets. The company is governed by a board of directors and a management team with deep experience in medical device services and healthcare operations. InfuSystem continues to invest in technology and infrastructure to meet evolving regulatory requirements and the shifting landscape of outpatient care.AI Generated. May Contain Errors. Read More InfuSystem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreINFU MarketRank™: InfuSystem scored higher than 89% of companies evaluated by MarketBeat, and ranked 64th out of 849 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingInfuSystem has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialInfuSystem has a consensus price target of $15.00, representing about 65.2% upside from its current price of $9.08.Amount of Analyst CoverageInfuSystem has received no research coverage in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 151.36, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.85.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 151.36, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.66.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 3.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for INFU. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. News and Social Media3.7 / 5News SentimentN/A News SentimentInfuSystem has a news sentiment score of 1.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for InfuSystem this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for INFU on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership4.7 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of InfuSystem in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $131,490.00 in company stock, which represents 0.0718% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $131,490.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.80% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INFU Stock News HeadlinesInfuSystem: A Good Time To Buy Before A Potential BreakoutJune 23 at 2:00 AM | seekingalpha.comInfuSystem announces $20M stock repurchase programMay 19, 2026 | seekingalpha.comBill Gates said this would never work. Then he wrote a $100M check.Bill Gates spent a decade insisting this energy source couldn't supply more than 5% of global power. Then he toured a construction site in the Nevada desert and told Bloomberg he now believes it could reach 20%. He followed that reversal with a $100 million investment. Facebook's co-founder added $462 million. Tesla's co-founder and Norway's sovereign wealth fund also took positions. One company - 60 years of operating history, revenue approaching $1 billion - sits at the center of all of it, with a July 4th catalyst that locks in its competitive advantage for eight years.June 24 at 1:00 AM | Behind the Markets (Ad)InfuSystem Announces New $20 Million Share Repurchase ProgramMay 18, 2026 | tipranks.comInfuSystem Announces $20 Million Stock Repurchase ProgramMay 18, 2026 | businesswire.comInfuSystem Stockholders Approve Expanded Equity Plan and BoardMay 14, 2026 | theglobeandmail.comInfuSystem Appoints Beverly Huss as New Board ChairMay 14, 2026 | tipranks.comInfuSystem Holdings, Inc. (INFU) Shareholder/Analyst Call Prepared Remarks TranscriptMay 11, 2026 | seekingalpha.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $8.97 at the beginning of the year. Since then, INFU stock has increased by 1.2% and is now trading at $9.08. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) issued its quarterly earnings data on Thursday, November, 7th. The company reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. The company earned $35.32 million during the quarter, compared to analyst estimates of $35.50 million. InfuSystem had a trailing twelve-month return on equity of 2.78% and a net margin of 1.12%. Is InfuSystem buying back stock? InfuSystem's board initiated a stock buyback program on Tuesday, May 19th 2026, which authorizes the company to buy back $20,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 10.3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's board believes its shares are undervalued. Who are InfuSystem's major shareholders? Top institutional investors of InfuSystem include Punch & Associates Investment Management Inc. (4.15%), Dimensional Fund Advisors LP (2.94%), Renaissance Technologies LLC (2.81%) and Heartland Advisors Inc. (2.53%). Insiders that own company stock include Richard Dilorio, Carrie Lachance, Barry G Steele, Scott Shuda, Paul Andrew Gendron, R Rimmy Malhotra, Addam Chupa, Ralph F Boyd Jr and Kenneth D Eichenbaum. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX). Company Calendar Last Earnings11/07/2024Today6/24/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 INFU's financial health is in the Green zone, according to TradeSmith. INFU has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees410Year Founded2005Price Target and Rating Average Price Target for InfuSystem$15.00 High Price Target$15.00 Low Price Target$15.00 Potential Upside/Downside+65.2%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.38 Trailing P/E Ratio151.36 Forward P/E Ratio60.53 P/E GrowthN/ANet Income$870 thousand Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.59 Sales & Book Value Annual Sales$142.40 million Price / Sales1.29 Cash Flow$0.71 per share Price / Cash Flow12.79 Book Value$2.47 per share Price / Book3.68Miscellaneous Outstanding Shares20,182,000Free Float19,095,000Market Cap$183.25 million OptionableOptionable Beta1.43 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:INFU) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersFour winners over 400%. Here's #5CFA and CMT analyst Garrett Goggin called G2 Goldfields before it rose 1,023%, Reunion Gold before 538%, Highl...Golden Portfolio | SponsoredMy feud with Zohran MamdaniNearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...Stansberry Research | SponsoredBig Oil knew about this for 50 yearsIn the 1970s, Chevron, Unocal, and Texaco all drilled the same energy source - and walked away to protect oil ...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredKarp just filed Form 144On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...Porter & Company | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredMy #1 Way to Gain Exposure to Anthropic Before It IPOsAnthropic just filed with the SEC to go public at a $965 billion valuation - and Wall Street veteran Marc Chai...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
